Global Biotech Ingredients Market Size to worth USD 4.40 Billion by 2033
According to a research report published by Spherical Insights & Consulting, The Global Biotech Ingredients Market Size is Expected to Grow from USD 2.05 Billion in 2023 to USD 4.40 Billion by 2033, at a CAGR of 7.94 % during the forecast period 2023-2033.
Browse key industry insights spread across 210 pages with 110 Market data tables and figures & charts from the report on the Global Biotech Ingredients Market Size, Share, and COVID-19 Impact Analysis, By Product (Flavors, Fragrances, and Active Cosmetic Ingredients), By Application (Dairy Products, Beverages, Confectionery, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.
The biotech ingredients market comprises biologically derived compounds that are utilized across various industries, including pharmaceuticals, cosmetics, food & beverages, and agriculture. These ingredients are produced through biotechnological processes such as fermentation, enzymatic synthesis, and cell culture, ensuring sustainability and high efficacy compared to conventional synthetic alternatives. The increasing demand for eco-friendly and bio-based products has significantly contributed to the market’s growth. Several factors are driving the expansion of the biotech ingredients market. The rising preference for natural and sustainable ingredients in personal care and pharmaceutical formulations is a key growth driver. Additionally, biotechnology and synthetic biology advancements have enhanced production efficiency, reduced costs, and increased adoption across multiple industries. Stringent regulatory frameworks promoting the use of bio-based ingredients, coupled with growing consumer awareness regarding environmental sustainability, are further propelling market expansion. However, certain challenges may restrain market growth. High production costs associated with biotechnological processes and the complexities involved in large-scale manufacturing pose significant barriers.
The active cosmetic ingredients segment accounted for the highest share in 2023 and is expected to grow at a significant CAGR during the forecast period.
Based on the product, the biotech ingredients market is divided into flavors, fragrances, and active cosmetic ingredients. Among these, the active cosmetic ingredients segment accounted for the largest share in 2023 and is expected to grow at a significant CAGR during the forecast period. This dominance is attributed to the increasing consumer demand for natural and sustainable components in personal care products. Biotechnologically derived active ingredients, such as peptides, polysaccharides, and bioactive compounds, are favored for their efficacy and eco-friendly profiles.
The dairy products segment accounted for the largest share in 2023 and is expected to grow at a significant CAGR during the forecast period.
Based on the application, the biotech ingredients market is classified into dairy products, beverages, confectionery, and others. Among these, the dairy products segment accounted for the largest share in 2023 and is expected to grow at a significant CAGR during the forecast period. This prominence is largely due to the increasing demand for biotech-derived flavors and fragrances in the food and beverage industry.
North America is estimated to hold the greatest biotech ingredients market share over the forecast period.
North America is estimated to hold the greatest biotech ingredients market share over the forecast period. It is brought about by advanced technology in producing biotech ingredients. Methods that include genetic engineering and recombinant DNA technology have become so efficient and specific in ingredient manufacturing, such that highly individualized treatments could be produced based on the requirements of a specific patient. In a way, personalized medicine, an emerging significant health trend, stands to benefit highly from such aspects.
Asia Pacific is predicted to have the fastest CAGR growth in the biotech ingredients market over the forecast period. The growing number of chronic diseases such as cardiovascular diseases, cancer, and diabetes require more effective treatment. For their efficacy, therapeutic solutions now mainly depend on the biotech ingredient. It has increased the demand for effective biotech ingredients within the pharmaceutical industry, thereby considerably increasing their growth.
Company Profiling
Major key players in the biotech ingredients market are Fermenta Biotech Limited, Titan Biotech, Conagen, Inc., Advanced Biotech, Bell Flavors & Fragrances, Inc., Merck KGaA, International Flavors & Fragrances, Inc., Amyris, dsm-firmenich, Symrise, and Evonik Industries.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Developments
- In March 2024, Roquette acquired IFF Pharma Solutions, a producer of excipients for oral dosage solution. This acquisition was likely to strengthen Roquette’s position in the market.
Market Segment
This study forecasts global, regional, and country revenue from 2023 to 2033. Spherical Insights has segmented the biotech ingredients market based on the below-mentioned segments:
Global Biotech Ingredients Market, By Product
- Flavors
- Fragrances
- Active Cosmetic Ingredients
Global Biotech Ingredients Market, By Application
- Dairy Products
- Beverages
- Confectionery
- Others
Global Biotech Ingredients Market, By Regional Analysis
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa